Biommune Technologies In (IMU.CA) Stock Price & Overview

TSX-V:IMU

Current stock price

0.44
-0.04 (-8.33%)
At close:
-0.44 (-100%)
After Hours:

The current stock price of IMU.CA is 0.44 null. Today IMU.CA is down by -8.33%. In the past month the price decreased by -3.3%. In the past year, price increased by 25.71%.

IMU.CA Key Statistics

52-Week Range0.33 - 0.85
Current IMU.CA stock price positioned within its 52-week range.
1-Month Range0.44 - 0.55
Current IMU.CA stock price positioned within its 1-month range.
Market Cap
14.321M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.05
Dividend Yield
N/A

IMU.CA Stock Performance

Today
-8.33%
1 Week
-5.38%
1 Month
-3.30%
3 Months
-34.33%
Longer-term
6 Months -26.67%
1 Year +25.71%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

IMU.CA Stock Chart

Biommune Technologies In / IMU Daily stock chart

IMU.CA Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to IMU.CA. When comparing the yearly performance of all stocks, IMU.CA is a bad performer in the overall market: 61.12% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
IMU.CA Full Technical Analysis Report

IMU.CA Earnings

Next Earnings DateN/A
Last Earnings DateN/A
IMU.CA Earnings History

IMU.CA Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
IMU.CA Forecast & Estimates

IMU.CA Financial Highlights

Over the last trailing twelve months IMU.CA reported a non-GAAP Earnings per Share(EPS) of -0.05.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)N/A
Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
IMU.CA financials

IMU.CA Ownership

Ownership
Inst OwnersN/A
Shares32.55M
FloatN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
IMU.CA Ownership

About IMU.CA

Company Profile

bioMmune Technologies Inc is a biopharmaceutical company. The Company is engaged in the research and development of products for the treatment of cancers, and for improvement of the immune system.

Company Info

Biommune Technologies In

400 Burrard Street

Vancouver BC V6C 3A6

CEO: Patrick W. Gray

Phone: +1 604 880-7250

Biommune Technologies In / IMU.CA FAQ

What does IMU do?

bioMmune Technologies Inc is a biopharmaceutical company. The Company is engaged in the research and development of products for the treatment of cancers, and for improvement of the immune system.


Can you provide the latest stock price for Biommune Technologies In?

The current stock price of IMU.CA is 0.44 null. The price decreased by -8.33% in the last trading session.


Does Biommune Technologies In pay dividends?

IMU.CA does not pay a dividend.


How is the ChartMill rating for Biommune Technologies In?

IMU.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


How is the valuation of Biommune Technologies In (IMU.CA) based on its PE ratio?

Biommune Technologies In (IMU.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).